Abstract
In order to identify proteins that bind to the PDZ domain of Erbin, we tested the C-termini of several proteins in a yeast two-hybrid assay. ErbB2, APC, β-catenin, c-Rel and HTLV-1 Tax were identified as ligands of the PDZ domain of Erbin. The interactions were verified by co-immunoprecipitation experiments. These findings demonstrate the promiscuity of the PDZ domain of Erbin.
Keywords: Erbin, PDZ domain, ErbB2, APC, c-Rel, HTLV-1 Tax
Protein & Peptide Letters
Title: Interaction Partners of the PDZ Domain of Erbin
Volume: 13 Issue: 9
Author(s): Angelika Ress and Karin Moelling
Affiliation:
Keywords: Erbin, PDZ domain, ErbB2, APC, c-Rel, HTLV-1 Tax
Abstract: In order to identify proteins that bind to the PDZ domain of Erbin, we tested the C-termini of several proteins in a yeast two-hybrid assay. ErbB2, APC, β-catenin, c-Rel and HTLV-1 Tax were identified as ligands of the PDZ domain of Erbin. The interactions were verified by co-immunoprecipitation experiments. These findings demonstrate the promiscuity of the PDZ domain of Erbin.
Export Options
About this article
Cite this article as:
Ress Angelika and Moelling Karin, Interaction Partners of the PDZ Domain of Erbin, Protein & Peptide Letters 2006; 13 (9) . https://dx.doi.org/10.2174/092986606778256126
DOI https://dx.doi.org/10.2174/092986606778256126 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanoparticle-based Cerebral Drug-Delivery Systems and Antiangiogenic Approach in Gliomas Treatment
Recent Patents on Nanotechnology A Retrospective Study on <i>Gloriosa superba</i> and Its Main Active Constituents
The Natural Products Journal The Role of Snail in EMT and Tumorigenesis
Current Cancer Drug Targets Patent Selections:
Recent Patents on Regenerative Medicine Review of and Perspectives on the Toxicology of Graphene-based Materials
Current Drug Metabolism Endothelial Cell Aging and Apoptosis in Prevention and Disease: E-Selectin Expression and Modulation As A Model
Current Pharmaceutical Design Regulation of Autophagy in Oxygen-Dependent Cellular Stress
Current Pharmaceutical Design Brain Tumor Segmentation Using Deep Belief Networks and Pathological Knowledge
CNS & Neurological Disorders - Drug Targets Anti-Tumor Mechanisms of Novel 3-(4-Substituted Benzyl)-5-Isopropil-5- Phenylhydantoin Derivatives in Human Colon Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry Evolutionary Significance of Iodine
Current Chemical Biology Role of Focal Adhesion Kinase in Human Cancer: A Potential Target for Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Immune Responses to Fungal Infections and Therapeutic Implications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Role of Zebrafish in Chemical Genetics
Current Medicinal Chemistry Histone Modifications as Molecular Targets in Nasopharyngeal Cancer
Current Medicinal Chemistry Clinical Application of Human Oocyte Cryopreservation
Reviews on Recent Clinical Trials Nanobiotechnological Approaches to Overcome Drug Resistance in Breast Cancer
Current Cancer Drug Targets Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review
Current Pharmaceutical Design The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine A Decrease in the Cellular Phosphodiester to Phosphomonoester Lipid Ratio is Characteristic of HIV-1 Infection
Current HIV Research Molecular Targeted Therapy in Prevalent Tumors: Learning from the Past and Future Perspectives
Current Clinical Pharmacology